Friday, August 23, 2019
Redactor's Choice
You are here: Home / Sources / Business & Entrepreneurs / Bayer HealthCare contributes to global fight against parasitic diseases
Bayer HealthCare contributes to global fight against parasitic diseases

Bayer HealthCare contributes to global fight against parasitic diseases

  • Germany
  • Research findings from new studies support international efforts against endoparasites, ectoparasites and protozoa. Monheim/Perth, August 26, 2013 – Diseases transmitted by parasites threaten the health of both animals and humans. To support researchers in their fight against the transmission of these diseases, Bayer HealthCare is presenting more than 16 new scientific studies at the World Association for the Advancement of Veterinary Parasitology (WAAVP), the largest scientific meeting in this field. The research results include key findings in the areas of endoparasites, ectoparasites and protozoa.
  • Bayer AG

“The public health impact of parasitic diseases is of global significance,” said Dr. Dirk Ehle, Global Head of Bayer HealthCare’s Animal Health Division. “We are pleased to be able to bring this new information about parasites and parasitic diseases to the research community through the WAAVP.”

Important findings of the studies published at the congress include the epidemiology of endoparasites such as the lungworm Angyostrongylus vasorum. The study results show a global trend in the general migration of parasites into new geographic regions and highlight the need to act against them. The lungworm findings, for example, indicate it has migrated east within Europe and is now widely detected in Germany, Great Britain and Poland. The lungworm causes canine angiostrongylosis, a cardiopulmonary infection which can be fatal in dogs if left untreated.

The new findings emphasize that prevention against parasitic infections is now more important than ever. The study results are published in open access scientific journals, including “Parasitology Research”, and most of them are available as open access papers that are free to the general public.

New data on Bayer’s innovative flea and tick collar Seresto™ for cats and dogs will also be presented that confirm Seresto’s long term efficacy and demonstrate the potential to reduce the risk of vector borne diseases. Seresto has a unique polymer matrix which releases a consistent, low-dose of active ingredients to the animal’s skin and hair that protects cats and dogs from fleas and ticks for up to eight months.

“A major theme of this year’s conference is ‘One Health’, an overarching approach to combine all natural science disciplines to achieve optimal health for people, animals and the environment,” explained Prof. Dr. Norbert Mencke, Head of Global Veterinary Services for Bayer HealthCare’s Animal Health Division. “Under the ‘One Health’ umbrella, we continue to support basic research that contributes to the fight against zoonotic diseases transmitted by parasites. Bayer’s mission of “Science For a Better Life” embodies the concept of ‘One Health’.”

The studies are available to the public at:

About Content Editor V

Content editor of PressCenter website.

Leave a Comment

Required fields are marked with *



You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Select the person with
the raised up hand *

Scroll To Top